These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 29196927)

  • 1. Characteristics of cerebellar glioblastomas in adults.
    Picart T; Barritault M; Berthillier J; Meyronet D; Vasiljevic A; Frappaz D; Honnorat J; Jouanneau E; Poncet D; Ducray F; Guyotat J
    J Neurooncol; 2018 Feb; 136(3):555-563. PubMed ID: 29196927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebellar high-grade gliomas do not present the same molecular alterations as supratentorial high-grade gliomas and may show histone H3 gene mutations.
    Tauziède-Espariat A; Saffroy R; Pagès M; Pallud J; Legrand L; Besnard A; Lacombe J; Lot G; Borha A; Tazi S; Adle-Biassette H; Polivka M; Lechapt E; Varlet P
    Clin Neuropathol; 2018; 37(5):209-216. PubMed ID: 29809131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Characterization of Adult Tumors Diagnosed as Cerebellar Glioblastomas Identifies Subgroups Associated With Prognosis.
    Picart T; Poncet D; Barritault M; Bauchet L; Zouaoui S; Guyotat J; Gabut M; Fina F; Honnorat J; Figarella-Branger D; Pallud J; Ducray F; Meyronet D; ;
    Am J Surg Pathol; 2023 Jan; 47(1):131-144. PubMed ID: 36418240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative Analysis of Survival Outcomes and Prognostic Factors of Supratentorial versus Cerebellar Glioblastoma in the Elderly: Does Location Really Matter?
    Chandra A; Lopez-Rivera V; Dono A; Brandel MG; Lewis C; O'Connor KP; Sheth SA; Ballester LY; Aghi MK; Esquenazi Y
    World Neurosurg; 2021 Feb; 146():e755-e767. PubMed ID: 33171326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of survival between cerebellar and supratentorial glioblastoma patients: surveillance, epidemiology, and end results (SEER) analysis.
    Jeswani S; Nuño M; Folkerts V; Mukherjee D; Black KL; Patil CG
    Neurosurgery; 2013 Aug; 73(2):240-6; discussion 246; quiz 246. PubMed ID: 23615082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of TP53 and RAS mutations on cerebellar glioblastomas.
    Milinkovic VP; Skender Gazibara MK; Manojlovic Gacic EM; Gazibara TM; Tanic NT
    Exp Mol Pathol; 2014 Oct; 97(2):202-7. PubMed ID: 25036404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glioblastoma in neurofibromatosis 1 patients without IDH1, BRAF V600E, and TERT promoter mutations.
    Shibahara I; Sonoda Y; Suzuki H; Mayama A; Kanamori M; Saito R; Suzuki Y; Mashiyama S; Uenohara H; Watanabe M; Kumabe T; Tominaga T
    Brain Tumor Pathol; 2018 Jan; 35(1):10-18. PubMed ID: 29138945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined analysis of TERT, EGFR, and IDH status defines distinct prognostic glioblastoma classes.
    Labussière M; Boisselier B; Mokhtari K; Di Stefano AL; Rahimian A; Rossetto M; Ciccarino P; Saulnier O; Paterra R; Marie Y; Finocchiaro G; Sanson M
    Neurology; 2014 Sep; 83(13):1200-6. PubMed ID: 25150284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome and prognostic factors in adult cerebellar glioblastoma.
    Babu R; Sharma R; Karikari IO; Owens TR; Friedman AH; Adamson C
    J Clin Neurosci; 2013 Aug; 20(8):1117-21. PubMed ID: 23706183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation among pathology, genotype, and patient outcomes in glioblastoma.
    Homma T; Fukushima T; Vaccarella S; Yonekawa Y; Di Patre PL; Franceschi S; Ohgaki H
    J Neuropathol Exp Neurol; 2006 Sep; 65(9):846-54. PubMed ID: 16957578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diffuse Midline Gliomas with Histone H3-K27M Mutation: A Series of 47 Cases Assessing the Spectrum of Morphologic Variation and Associated Genetic Alterations.
    Solomon DA; Wood MD; Tihan T; Bollen AW; Gupta N; Phillips JJ; Perry A
    Brain Pathol; 2016 Sep; 26(5):569-80. PubMed ID: 26517431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. H3 K27M-mutant gliomas in adults vs. children share similar histological features and adverse prognosis.
    Kleinschmidt-DeMasters BK; Mulcahy Levy JM
    Clin Neuropathol; 2018; 37 (2018)(2):53-63. PubMed ID: 29393845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TERT promoter mutations in primary and secondary glioblastomas.
    Nonoguchi N; Ohta T; Oh JE; Kim YH; Kleihues P; Ohgaki H
    Acta Neuropathol; 2013 Dec; 126(6):931-7. PubMed ID: 23955565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characteristics and pathogenesis of cerebellar glioblastoma.
    Takahashi Y; Makino K; Nakamura H; Hide T; Yano S; Kamada H; Kuratsu J
    Mol Med Rep; 2014 Nov; 10(5):2383-8. PubMed ID: 25199771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TERT promoter mutations and rs2853669 polymorphism: prognostic impact and interactions with common alterations in glioblastomas.
    Nencha U; Rahimian A; Giry M; Sechi A; Mokhtari K; Polivka M; Schmitt Y; Di Stefano AL; Alentorn A; Labussière M; Sanson M
    J Neurooncol; 2016 Feb; 126(3):441-6. PubMed ID: 26608520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomarker-based prognostic stratification of young adult glioblastoma.
    Zhang RQ; Shi Z; Chen H; Chung NY; Yin Z; Li KK; Chan DT; Poon WS; Wu J; Zhou L; Chan AK; Mao Y; Ng HK
    Oncotarget; 2016 Jan; 7(4):5030-41. PubMed ID: 26452024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management, functional outcomes and survival in a French multicentric series of 118 adult patients with cerebellar glioblastoma.
    Picart T; Meyronet D; Pallud J; Dumot C; Metellus P; Zouaoui S; Berhouma M; Ducray F; Bauchet L; Guyotat J; ;
    J Cancer Res Clin Oncol; 2021 Jun; 147(6):1843-1856. PubMed ID: 33399987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. H3K27M mutation in adult cerebellar glioblastoma.
    Lu VM; Akinduro OO; Daniels DJ
    J Clin Neurosci; 2020 Jan; 71():316-317. PubMed ID: 31843430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. OLIG2 expression level could be used as an independent prognostic factor for patients with cerebellar Glioblastoma (cGBM).
    Zhou J; Shi LF; Wang Z; Li M; Zhang JS; Mao Y; Hua W
    Clinics (Sao Paulo); 2023; 78():100120. PubMed ID: 37001387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of genetic subgroups in adult supra tentorial gliomas by pre- and intraoperative parameters.
    Nakae S; Murayama K; Sasaki H; Kumon M; Nishiyama Y; Ohba S; Adachi K; Nagahisa S; Hayashi T; Inamasu J; Abe M; Hasegawa M; Hirose Y
    J Neurooncol; 2017 Jan; 131(2):403-412. PubMed ID: 27837434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.